CROWN BIOSCIENCE
LIVE

Serial Number

97409044

Owner

Crown Bioscience, Inc.

Attorney

Yi Zhang

First Use Date

Oct 25, 2021

Filing Date

May 13, 2022

Add to watchlist:

No watchlists yet
View on USPTO

CROWN BIOSCIENCE Trademark

Serial Number: 97409044

CROWN BIOSCIENCE is a trademark filed by Crown Bioscience, Inc. on May 13, 2022. The trademark is classified under Class 9 (Computers & Electronics), Class 42 (Computer & Scientific), Class 44 (Medical Services), Class 31 (Natural Agricultural Products). The application is currently pending registration.

Owner Contact Info

Crown Bioscience, Inc.

16550 W. Bernardo Dr., Bld. 5, Suite 525
San Diego, CA 92127

Entity Type: 03

Trademark Details

Filing Date

May 13, 2022

Registration Date

Not Registered

First Use Anywhere

October 25, 2021

First Use in Commerce

October 25, 2021

Published for Opposition

December 12, 2023

Goods & Services

(Based on Use in Commerce) Consulting services in the field of biotechnology; Laboratory research services relating to pharmaceuticals; Medical and scientific research in the field of cancer treatment and diagnosis; Medical laboratory services; Medical research services in the field of cancer; Pharmaceutical drug development services; Providing a members-only website featuring technology which provides members with the ability to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a secured-access, members only website featuring technology that gives members the ability to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a web site featuring technology that enables users to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring non-downloadable software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring on-line non-downloadable software that enables users to search genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing a website featuring resources, namely, non-downloadable software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Providing reagent sample testing and diagnostic services for others for scientific research purposes; Research and development of pharmaceuticals for the treatment of age-related diseases and cancer; Research and development of vaccines and medicines; Scientific and technological services, namely, analyzing preclinical oncology efficacy in the field of medical treatment; Scientific laboratory services; Scientific research for medical purposes in the area of cancerous diseases; Technical research in the field of pharmaceutical studies

(Based on Use in Commerce) Downloadable computer application software for mobile phones, namely, software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable computer software for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable mobile applications for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data; Downloadable software in the nature of a mobile application for searching genomic data, pharmaceutical data, histological data, xenograft data, human cell line data, derived xenografts data, homografts of mouse tumor models data, mouse cell line data, syngeneic models data, and other animal models, specifically, mice and monkeys data

(Based on Intent to Use) Live animals; Live animals, namely, rodent animal, specifically, rats; Live laboratory animals

(Based on Use in Commerce) Drug use screening services; Drug use testing services; Drug, alcohol and DNA screening for medical purposes; Medical screening; Medical services, namely, pre-employment drug screening; Providing information in the field of cancer prevention, screening, diagnosis and treatment

Filing History

NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 17, 2026 EXRA
SOU EXTENSION 4 GRANTED
Feb 17, 2026 EX4G
SOU TEAS EXTENSION RECEIVED
Feb 6, 2026 EEXT
SOU EXTENSION 4 FILED
Feb 5, 2026 EXT4
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Sep 30, 2025 EXRA
SOU EXTENSION 3 GRANTED
Sep 29, 2025 EX3G
SOU EXTENSION RECEIVED WITH TEAS PETITION
Sep 11, 2025 TPEX
NOTICE OF REVIVAL - E-MAILED
Sep 11, 2025 NREV
PETITION TO REVIVE-GRANTED
Sep 11, 2025 PETG
TEAS PETITION TO REVIVE RECEIVED
Sep 11, 2025 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 8, 2025 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 8, 2025 ABN6
SOU EXTENSION 3 FILED
Aug 5, 2025 EXT3
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Feb 6, 2025 EXRA
SOU EXTENSION 2 GRANTED
Feb 6, 2025 EX2G
SOU EXTENSION 2 FILED
Feb 6, 2025 EXT2
SOU TEAS EXTENSION RECEIVED
Feb 5, 2025 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Dec 3, 2024 EXRA
SOU EXTENSION 1 GRANTED
Dec 3, 2024 EX1G
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Dec 2, 2024 AITU
SOU EXTENSION RECEIVED WITH TEAS PETITION
Sep 9, 2024 TPEX
NOTICE OF REVIVAL - E-MAILED
Sep 9, 2024 NREV
PETITION TO REVIVE-GRANTED
Sep 9, 2024 PETG
TEAS PETITION TO REVIVE RECEIVED
Sep 9, 2024 PROA
ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILED
Sep 9, 2024 MAB6
ABANDONMENT - NO USE STATEMENT FILED
Sep 9, 2024 ABN6
SOU EXTENSION 1 FILED
Aug 6, 2024 EXT1
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Feb 6, 2024 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Dec 12, 2023 NPUB
PUBLISHED FOR OPPOSITION
Dec 12, 2023 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Nov 22, 2023 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Nov 7, 2023 CNSA
TEAS/EMAIL CORRESPONDENCE ENTERED
Nov 7, 2023 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 7, 2023 CRFA
ASSIGNED TO LIE
Nov 7, 2023 ALIE
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 5, 2023 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 6, 2023 GNRN
NON-FINAL ACTION E-MAILED
Mar 6, 2023 GNRT
NON-FINAL ACTION WRITTEN
Mar 6, 2023 CNRT
ASSIGNED TO EXAMINER
Mar 2, 2023 DOCK
NOTICE OF DESIGN SEARCH CODE E-MAILED
May 19, 2022 MDSC
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
May 18, 2022 NWOS
NEW APPLICATION ENTERED
May 17, 2022 NWAP